We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis (REViVALS-1A)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04632225
Recruitment Status : Completed
First Posted : November 17, 2020
Last Update Posted : November 7, 2022
Information provided by (Responsible Party):
Helixmith Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 11, 2022
Actual Study Completion Date : August 31, 2022